- Home
- LVLU vs ADVB Comparison
LVLU vs ADVB Comparison
Compare LVLU & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVLU
- ADVB
- Stock Information
- Founded
- LVLU 1996
- ADVB 2014
- Country
- LVLU United States
- ADVB United States
- Employees
- LVLU N/A
- ADVB N/A
- Industry
- LVLU Catalog/Specialty Distribution
- ADVB Medical Specialities
- Sector
- LVLU Consumer Discretionary
- ADVB Health Care
- Exchange
- LVLU Nasdaq
- ADVB Nasdaq
- Market Cap
- LVLU 18.4M
- ADVB 20.8M
- IPO Year
- LVLU 2021
- ADVB 2025
- Fundamental
- Price
- LVLU $3.62
- ADVB $0.38
- Analyst Decision
- LVLU Hold
- ADVB
- Analyst Count
- LVLU 2
- ADVB 0
- Target Price
- LVLU $15.00
- ADVB N/A
- AVG Volume (30 Days)
- LVLU 323.5K
- ADVB 2.3M
- Earning Date
- LVLU 08-13-2025
- ADVB 08-19-2025
- Dividend Yield
- LVLU N/A
- ADVB N/A
- EPS Growth
- LVLU N/A
- ADVB N/A
- EPS
- LVLU N/A
- ADVB N/A
- Revenue
- LVLU $302,783,000.00
- ADVB N/A
- Revenue This Year
- LVLU N/A
- ADVB N/A
- Revenue Next Year
- LVLU $2.53
- ADVB N/A
- P/E Ratio
- LVLU N/A
- ADVB N/A
- Revenue Growth
- LVLU N/A
- ADVB N/A
- 52 Week Low
- LVLU $2.98
- ADVB $0.34
- 52 Week High
- LVLU $28.05
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- LVLU 42.51
- ADVB N/A
- Support Level
- LVLU $3.60
- ADVB N/A
- Resistance Level
- LVLU $4.10
- ADVB N/A
- Average True Range (ATR)
- LVLU 0.61
- ADVB 0.00
- MACD
- LVLU 0.05
- ADVB 0.00
- Stochastic Oscillator
- LVLU 32.66
- ADVB 0.00
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.